Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency (Q33739974)

29 July 2017

1 reference

title

Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency (English)

1 reference

29 July 2017

Hellstern P

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

95

1 reference

29 July 2017

issue

4 Suppl 1

1 reference

29 July 2017

page(s)

S7-12

1 reference

Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Management of acquired coagulation disorders in emergency and intensive-care medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Why prescribe highly purified factor VIII and IX concentrates?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Large scale preparation of nonthrombogenic prothrombin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Activation of clotting factors in prothrombin complex concentrates as demonstrated by clotting assays for factors IXa and Xa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

The thrombogenicity of prothrombin complex concentrates: I. The relationship between in vitro characteristics and in vivo thrombogenicity in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Comparison of different prothrombin complex concentrates--in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

In Vitro Spontaneous Thrombin Generation in Human Factor-IX Concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Thrombogenicity of factor IX concentrates: in vitro and in vivo (rabbit) studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

Emergency reversal of anticoagulation after intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900078-X

7 January 2021

10.1016/S0049-3848(99)00078-X

Identifiers

DOI

1 reference

29 July 2017

1 reference